DANAHER CORPORATION's ticker is DHR and the CUSIP is 235851102. A total of 2,008 filers reported holding DANAHER CORPORATION in Q1 2022. The put-call ratio across all filers is 1.38 and the average weighting 0.6%.
About DANAHER CORPORATION
Danaher Corporation is a global science and technology company that designs, manufactures, and markets innovative products and services to professional, medical, industrial, and commercial customers. The company operates through four segments: Life Sciences, Diagnostics, Dental, and Environmental & Applied Solutions.
Danaher's Life Sciences segment provides a range of research tools to scientists around the world, including mass spectrometry, chromatography, and automation systems. The Diagnostics segment offers a broad range of diagnostic products, including clinical chemistry, immunoassay, microbiology, and molecular diagnostic systems. The Dental segment provides a range of dental equipment and consumables, including imaging systems, dental instruments, and consumables. The Environmental & Applied Solutions segment offers a range of products and services to help customers protect the environment and improve productivity.
Danaher has a strong track record of growth and innovation, driven by its focus on continuous improvement and customer satisfaction. The company has a culture of operational excellence, which has enabled it to consistently deliver high-quality products and services to its customers. Danaher's management team is highly experienced and has a proven track record of creating value for shareholders.
In conclusion, Danaher Corporation is a well-established and innovative company that is well-positioned to continue delivering strong growth and value to its shareholders. With its focus on operational excellence and customer satisfaction, Danaher is a company that investors should keep an eye on.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $641,322,374 | -31.6% | 2,584,935 | -33.8% | 0.22% | -26.9% |
| Q2 2023 | $937,553,760 | -44.0% | 3,906,474 | -41.2% | 0.31% | -46.2% |
| Q1 2023 | $1,675,042,717 | -31.3% | 6,645,940 | -27.6% | 0.57% | -32.7% |
| Q4 2022 | $2,436,585,327 | -9.6% | 9,180,112 | -12.0% | 0.85% | -15.5% |
| Q3 2022 | $2,694,594,000 | -11.4% | 10,432,430 | -13.0% | 1.01% | -4.0% |
| Q2 2022 | $3,041,684,000 | -16.7% | 11,997,806 | -3.6% | 1.05% | -3.0% |
| Q1 2022 | $3,652,433,000 | -13.5% | 12,451,612 | -3.0% | 1.08% | -6.4% |
| Q4 2021 | $4,221,375,000 | +5.3% | 12,830,540 | -2.6% | 1.16% | -1.4% |
| Q3 2021 | $4,009,171,000 | +6.1% | 13,169,003 | -6.4% | 1.17% | +6.6% |
| Q2 2021 | $3,777,299,000 | +13.2% | 14,075,488 | -5.1% | 1.10% | +7.2% |
| Q1 2021 | $3,337,402,000 | +4.7% | 14,827,622 | +3.3% | 1.03% | +0.3% |
| Q4 2020 | $3,187,043,000 | -5.0% | 14,347,002 | -8.0% | 1.02% | -15.9% |
| Q3 2020 | $3,356,396,000 | +19.3% | 15,587,216 | -2.0% | 1.22% | +9.6% |
| Q2 2020 | $2,812,623,000 | +21.9% | 15,905,804 | -4.6% | 1.11% | +0.8% |
| Q1 2020 | $2,307,919,000 | -19.2% | 16,674,513 | -10.4% | 1.10% | +2.5% |
| Q4 2019 | $2,855,606,000 | +2.0% | 18,605,725 | -4.1% | 1.07% | -4.5% |
| Q3 2019 | $2,800,695,000 | -1.1% | 19,391,365 | -2.2% | 1.12% | -2.6% |
| Q2 2019 | $2,832,487,000 | +6.8% | 19,818,696 | -1.4% | 1.15% | +3.2% |
| Q1 2019 | $2,653,282,000 | +24.2% | 20,097,563 | -3.0% | 1.12% | +9.1% |
| Q4 2018 | $2,136,355,000 | -6.4% | 20,717,178 | -1.4% | 1.02% | +9.0% |
| Q3 2018 | $2,282,735,000 | +7.9% | 21,008,046 | -2.0% | 0.94% | +3.8% |
| Q2 2018 | $2,114,865,000 | +0.6% | 21,431,552 | -0.2% | 0.91% | +0.6% |
| Q1 2018 | $2,102,210,000 | +4.6% | 21,470,844 | -0.9% | 0.90% | +6.9% |
| Q4 2017 | $2,010,583,000 | +7.2% | 21,661,088 | -1.0% | 0.84% | +3.4% |
| Q3 2017 | $1,876,224,000 | +9.2% | 21,872,507 | +7.5% | 0.82% | +7.0% |
| Q2 2017 | $1,717,414,000 | -0.8% | 20,350,918 | +0.5% | 0.76% | -6.0% |
| Q1 2017 | $1,731,974,000 | +9.0% | 20,249,902 | -0.8% | 0.81% | +4.4% |
| Q4 2016 | $1,588,622,000 | -2.5% | 20,408,826 | -1.8% | 0.78% | -2.0% |
| Q3 2016 | $1,628,962,000 | -31.1% | 20,780,228 | -11.3% | 0.79% | -33.5% |
| Q2 2016 | $2,365,811,000 | +4.8% | 23,423,868 | -1.5% | 1.19% | +1.7% |
| Q1 2016 | $2,256,389,000 | -0.4% | 23,786,507 | -2.5% | 1.17% | -3.1% |
| Q4 2015 | $2,265,703,000 | +5.0% | 24,393,886 | -3.7% | 1.21% | +0.3% |
| Q3 2015 | $2,158,385,000 | -99.9% | 25,330,192 | -3.4% | 1.21% | +5.6% |
| Q2 2015 | $2,244,700,372,000 | -1.6% | 26,226,199 | -2.4% | 1.14% | -1.0% |
| Q1 2015 | $2,280,349,001,000 | -1.5% | 26,859,234 | -0.6% | 1.15% | -2.0% |
| Q4 2014 | $2,315,066,047,000 | +111594.8% | 27,010,454 | -1.0% | 1.18% | +7.5% |
| Q3 2014 | $2,072,672,000 | -2.5% | 27,279,183 | +1.0% | 1.10% | -1.4% |
| Q2 2014 | $2,126,457,000 | -99.9% | 27,009,482 | +1.1% | 1.11% | +1.5% |
| Q1 2014 | $2,002,863,825,000 | -2.6% | 26,704,851 | +0.3% | 1.10% | -5.0% |
| Q4 2013 | $2,055,549,434,000 | +9.7% | 26,626,288 | -1.5% | 1.15% | -0.6% |
| Q3 2013 | $1,873,671,424,000 | +4.8% | 27,029,305 | -4.3% | 1.16% | -4.1% |
| Q2 2013 | $1,788,170,879,000 | – | 28,249,145 | – | 1.21% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RobecoSam USA, Inc. | 74,961 | $7,572,000 | 9.43% |
| Corvid Peak Capital Management, LLC | 250,000 | $25,250,000 | 8.54% |
| CORTLAND ASSOCIATES INC/MO | 310,508 | $31,361,000 | 6.88% |
| Southpoint Capital Advisors LP | 1,250,000 | $126,250,000 | 6.75% |
| GREEN VALLEY INVESTORS LLC | 2,168,594 | $219,027,000 | 6.70% |
| DAVIS-REA LTD. | 75,080 | $7,595,000 | 5.39% |
| CADINHA & CO LLC | 247,143 | $24,961,000 | 5.35% |
| Espalier Global Management LLC | 47,100 | $4,757,000 | 5.25% |
| Spears Abacus Advisors LLC | 398,334 | $40,232,000 | 5.10% |
| GCA INVESTMENT MANAGEMENT, LLC | 158,064 | $15,964,000 | 5.01% |